XXII

2.045

3.99% -0.085

Dopo l'orario di chiusura: 2.10 0.055 +2.69%

22nd Century Group, Inc. (XXII)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.13

Aprire:

$2.14

Volume 24 ore:

28,871

Relative Volume:

0.95

Capitalizzazione di mercato:

$1.46M

Reddito:

$15.74M

Utile/perdita netta:

$-12.86M

Rapporto P/E:

-0.000442

EPS:

-4622.6032

Flusso di cassa netto:

$-8.71M

1 W Prestazione:

-10.31%

1M Prestazione:

-52.99%

6M Prestazione:

-97.40%

1 anno Prestazione:

-99.60%

Intervallo 1D:

$1.99

$2.1674

Intervallo di 1 settimana:

$1.99

$2.4992

Portata 52W:

$1.99

$646.50

22nd Century Group, Inc. Stock (XXII) Company Profile

Nome

22nd Century Group, Inc.

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

716-270-1523

Indirizzo

8560 Main Street, Williamsville, NY

Dipendente

Cinguettio

@_xxiicentury

Prossima data di guadagno

2026-11-03

Ultimi documenti SEC

XXII's Discussions on Twitter

Compare XXII vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
XXII 22nd Century Group, Inc.	2.045	1.52M	15.74M	-12.86M	-8.71M	-4,622.60
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-07-21	Iniziato	Alliance Global Partners	Buy
2022-06-15	Iniziato	Craig Hallum	Buy
2022-03-08	Iniziato	ROTH Capital	Buy
2021-07-23	Iniziato	Cowen	Outperform
2017-10-16	Reiterato	Chardan Capital Markets	Buy
2016-08-11	Reiterato	Chardan Capital Markets	Buy

Mostra tutto

22nd Century Group, Inc. Borsa (XXII) Ultime notizie

Sep 03, 2026

22nd Century Group Inc (NASDAQ: XXII) Share Price, XXII Stock News, XXII Share Price & Updates - kalkine.com.au

Sep 03, 2026

Sep 01, 2026

22nd Century Reports Mid-Year Update: 2,000 Outlets now, ~5,000 by Year-End; Improving Gross Margin - TradingView

Sep 01, 2026

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter - marketscreener.com

Sep 01, 2026

Aug 25, 2026

22nd Century Group (NASDAQ: XXII) investor reports 9.9% stake - Stock Titan

Aug 25, 2026

Aug 24, 2026

22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025 - kalkine.ca

Aug 24, 2026

Aug 20, 2026

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026 - The Manila Times

Aug 18, 2026

Cigarettes with 95% less nicotine than traditional ones; 22nd Century CEO will attend Sept. 15 event - Stock Titan

Aug 18, 2026

XXII: Low-nicotine VLN® cigarettes are expanding nationwide, targeting profitability by 2027 - TradingView

Aug 18, 2026

Aug 14, 2026

22nd Century Group, Inc. 2Q 2026: Revenue $2.86M, EPS ($104) — 10-Q Summary - TradingView

Aug 14, 2026

22nd Century Group (XXII) gains 6.7% shareholder position from Anson-related funds - Stock Titan

Aug 14, 2026

Form 8K 22nd Century Group Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

Aug 13, 2026

22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - kalkine.ca

Aug 13, 2026